NUCLEAR CATARACT: ROLE OF UV FILTERS AND THE LENS BARRIER
NUCLEAR CATARACT: ROLE OF UV FILTERS AND THE LENS BARRIER
批准号:
7291618
负责人:
ROGER J TRUSCOTT
金额:
$11.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2009-08-31
关键词:
AffectAgeAntioxidantsApplications GrantsArtsBiochemicalBlindnessCataractCell NucleusCellsConditionConnexinsCrystallinsDataDevelopmentDiffusionEyeFutureGlutathioneGrantHardnessHumanIndividualInterventionLeftLinkMIP geneMapsMeasuresMembraneModificationMolecularMovementNuclearNuclear ProteinNuclear ProteinsOxidative StressPharmaceutical PreparationsPhysiologyPlanetsPost-Translational Protein ProcessingPresbyopiaProteinsPublishingRangeReactionResearch PersonnelRoleShapesSiteSymptomsTechniquesTestingTimeWaterWorkage relatedbasecrosslinkinnovationlenslens proteinmiddle ageoxidationphysical propertypreventprogramsresidencesmall molecule
中文摘要
描述:老年性核性(臂)白内障是导致世界失明的主要原因。在过去的几年里,我们对ARN白内障的认识发生了一场革命。在那之前,基本上我们所知道的就是ARN白内障与晶状体蛋白质的深度氧化、不溶解、着色和交联性有关。目前还不清楚为什么这些晶状体的细胞核会发生这样的氧化变化。最近的进展表明,ARN白内障的发展是随着年龄的增长晶状体发生变化的直接结果。(包括发现晶状体变色的原因,以及允许晶状体中心氧化进行的生化/物理基础,最终导致白内障。)简单地说,抗氧化剂谷胱甘肽从皮质合成或还原的位置进入晶状体核的障碍在老年人身上形成。因此,年龄较大的正常人晶状体的细胞核对氧化应激很敏感。这些发现表明,ARN白内障的大部分(如果不是全部)特征可能是基于中年时晶状体屏障的开始以及随后核蛋白与活性分子(如紫外线过滤器)的氧化和反应来解释的。我们建议调查这一障碍在中年出现的原因。2004年12月,我们发现随着年龄的增长,正常晶状体的核经历了大量的硬度增加。这可能是障碍发展的原因吗?这项拨款申请的目的是调查这项建议。如果得到证实,这将对未来的白内障治疗产生重大影响,因为它带来了药物干预可能预防或推迟ARN白内障的希望。由于晶状体核在调节时必须经历重大的形状变化,了解这种巨大硬化的分子基础也可能影响我们对老花眼的理解。
英文摘要
DESCRIPTION: Age-related nuclear (ARM) cataract is a major cause of world blindness. There has been a revolution in our understanding of ARN cataract in the past few years. Up until that time, essentially all that was known was that ARN cataract was associated with profound oxidation, insolubilization, coloration and cross-linking of lens proteins. It was unclear why such oxidative changes occurred in the nuclei of these lenses. Recent advances suggest that ARN cataract develops as a direct result of changes in the lens that occur with age. (These include the discovery of a reason for lens coloration and also the biochemical/physical basis that allows oxidation in the centre of the lens to proceed; resulting ultimately in cataract.) Briefly, a barrier to the movement of the antioxidant, glutathione from its site of synthesis or reduction in the cortex, into the lens nucleus, forms in older individuals. Thus the nucleus of the older normal human lens becomes susceptible to oxidative stress. These findings suggest that most, if not all, of the features of ARN cataract may be explained on the basis of the onset of the lens barrier in middle age and the subsequent oxidation and reaction of the nuclear proteins with reactive molecules, such as UV filters. We propose to investigate the reason for the onset of the barrier at middle age. In December 2004 we showed that the nucleus of normal lenses undergoes a massive increase in hardness with age. Could this be the reason for the development of the barrier? It is the aim of this grant application to investigate this proposal. If confirmed, this would have major implications for future cataract treatment, since it offers hope that drug intervention may be possible to prevent, or delay, ARN cataract. Since the lens nucleus must undergo a major change in shape on accommodation, understanding the molecular basis of this enormous hardening may also impact on our understanding of presbyopia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUCLEAR CATARACT: ROLE OF UV FILTERS AND LENS BARRIER
-
批准号:6360842
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2001
-
负责人:ROGER J TRUSCOTT
-
依托单位:
NUCLEAR CATARACT: ROLE OF UV FILTERS AND THE LENS BARRIER
-
批准号:7142009
-
项目类别:
-
资助金额:$11.48万
-
财政年份:2001
-
负责人:ROGER J TRUSCOTT
-
依托单位:
NUCLEAR CATARACT: ROLE OF UV FILTERS AND LENS BARRIER
-
批准号:6665277
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2001
-
负责人:ROGER J TRUSCOTT
-
依托单位:
NUCLEAR CATARACT: ROLE OF UV FILTERS AND LENS BARRIER
-
批准号:6525136
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2001
-
负责人:ROGER J TRUSCOTT
-
依托单位:
NUCLEAR CATARACT: ROLE OF UV FILTERS AND THE LENS BARRIER
-
批准号:7498924
-
项目类别:
-
资助金额:$11.19万
-
财政年份:2001
-
负责人:ROGER J TRUSCOTT
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: